Amphastar Pharmaceuticals
AMPH
AMPH
270 hedge funds and large institutions have $1.47B invested in Amphastar Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 88 increasing their positions, 98 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
10% less repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 98
11% less first-time investments, than exits
New positions opened: 47 | Existing positions closed: 53
30% less capital invested
Capital invested by funds: $2.09B → $1.47B (-$622M)
Holders
270
Holding in Top 10
3
Calls
$3.17M
Puts
$2.61M
Top Buyers
| 1 | +$12.3M | |
| 2 | +$11.5M | |
| 3 | +$9.53M | |
| 4 |
BCM
Boone Capital Management
Atlanta,
Georgia
|
+$9.08M |
| 5 |
EIP
Epoch Investment Partners
New York
|
+$9.04M |
Top Sellers
| 1 | -$52.5M | |
| 2 | -$25.6M | |
| 3 | -$6.82M | |
| 4 |
BHWA
Beacon Harbor Wealth Advisors
Virginia Beach,
Virginia
|
-$6.38M |
| 5 |
D.E. Shaw & Co
New York
|
-$4.77M |